Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448539
Status:
TERMINATED
Last Update Posted:
2019-11-22
First Post:
2007-03-15
Brief Title:
Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Organization Data
Organization:
Eisai Inc
Class:
INDUSTRY
Study ID:
E2080-A001-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eisai Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None